Bloomberg Audio Studios, podcasts, radio news, The.
Stock Movers Report, your roundup of companies making moves in the stock market, harnessing the power of Bloomberg Data.
We have Avlon Parnell here with us to talk us through some of the big movers. She sees, Alan, what do you have for us? Yeah, we can go, and to start off with probably the biggest one of today. Intel, that's ticker i NTC jumping now about twenty four percent for it is to hit a record high. Actually that's after Intel reported a really big beat last night and
also a stronger than expected second quarter forecast. Ever, of course, actually writing that the company's new CEO really seems to be executing on a strategy that seems to be making Intel back onto the competitive track, and also worth mentioning that this is all basically based on AI.
So yeah, it's not a bit of an amazing, amazing move here. How about a cable and broadband company, Charter Communications. We had good numbers out of coompcast yesterday. That stock was up much for Charter today.
Exactly, Charter that's ticker cht R struggling today to say the least, down a roety about twenty three percent for its biggest inter day drop on record. That's after the cable company, as you mentioned behind Spectrum, reported weaker than
expected first quarter results. City writing that Charter's results were mixed as strategic volumes and also that broadband revenue underwhelmed, and also thought it was really interesting because, as you said, Comcast was a basically completely different story.
Yep, yep, And so that's sort of expectations. I think.
Yeah, let's take a look at big pharma. Yes, Eli, Lilly that's ticker ll Y also sliding about four point two percent today to hit its lowest inter day level since March, and that's after early prescription scripts data for its long awaited weight loss pill very much disappointed Wall Street. Lily's fat loss pill FOUNDEO generated just under four thousand prescriptions and it's second week since launching. By comparison, Novo's
wig Govi pill got more than eighteen thousand prescriptions. So while it's still way too early to say this is a good or bad situation, RBC is actually writing that while the comparisons this early into a launch are very much immateial Vondeo's uptake this week is likely to be received very negatively by investors, and we're already seeing that in the stock move.
The stock Moover's report from Bloomberg Radio. Check back with us throughout the day for the latest roundup of companies making news on Wall Street and for the latest market moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg dot com, and on Applecarplay and Android Auto with the Bloomberg Business app.